Oncorus Inc (ONCR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Theodore T. Ashburn
Employees:
80
450 KENDALL STREET, 5TH FLOOR, CAMBRIDGE, MA 02142
617-425-9200

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers.

Data derived from most recent annual or quarterly report
Market Cap 3.157 Million Shares Outstanding26.095 Million Avg 30-day Volume 13.776 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-3.48
Price to Revenue0.0 Debt to Equity0.6599 EBITDA-84.608 Million
Price to Book Value0.2885 Operating Margin0.0 Enterprise Value-15.465 Million
Current Ratio1.5 EPS Growth-0.279 Quick Ratio1.446
1 Yr BETA 0.0958 52-week High/Low 1.7 / 0.07 Profit Margin0.0
Operating Cash Flow Growth11.4246 Free Cash Flow to Firm (FCFF) TTM -52.98 Million Free Cash Flow to Equity (FCFE) TTM-80.034 Million
Altman Z-Score-6.2756

Are you looking for this stock instead?

View SEC Filings from ONCR instead.

View recent insider trading info

Oncorus Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ONCR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ONCR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-06-16 by SHEA BRIAN J.
  • 3: filed on 2023-05-22 by NOLTE ALEXANDER
  • 4: filed on 2022-12-30 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
  • 4: filed on 2022-12-27 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
  • 4: filed on 2022-12-21 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
  • 4: filed on 2022-12-15 by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
  • 4: filed on 2022-11-02 by HARBIN STEPHEN
  • 4: filed on 2022-06-24 by YANNI BARBARA
  • 4: filed on 2022-06-24 by RUBIN ERIC
  • 4: filed on 2022-06-24 by NAM SPENCER

    • Events (8k)

  • 8-K: filed on 2023-08-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2023-07-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2023-07-19:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-26:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-09:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-06-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-01:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-22:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-18:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-05-05:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SHEA BRIAN J. INTERIM CEO

    • Officer
    		 8,541 2023-06-06 1

    NOLTE ALEXANDER INTERIM CFO

    • Officer
    		 0 2023-05-09 1

    FLYNN JAMES E

    DEERFIELD MGMT HIF, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 8,211,439 2022-12-28 4

    HARBIN STEPHEN COO AND CHIEF OF STAFF

    • Officer
    		 150,000 2022-11-01 0

    EVNIN LUKE

    • Director
    		 12,500 2022-06-23 0

    CANUTE SCOTT A

    • Director
    		 12,500 2022-06-23 0

    FENTON MARY KAY

    • Director
    		 12,500 2022-06-23 0

    FINER MITCHELL H.

    • Director
    		 12,500 2022-06-23 0

    YANNI BARBARA

    • Director
    		 12,500 2022-06-23 0

    NAM SPENCER

    • Director
    		 12,500 2022-06-23 0

    RUBIN ERIC

    • Director
    		 12,500 2022-06-23 0

    FAMBROUGH DOUGLAS

    • Director
    		 0 2022-06-22 0

    WANSTALL RICK CFO AND TREASURER

    • Officer
    		 51,000 2022-05-25 0

    ASHBURN THEODORE PRESIDENT AND CEO

    • Officer
    • Director
    		 211,000 2022-03-01 0

    MCCABE JOHN P. CFO AND TREASURER

    • Officer
    		 90,000 2022-03-01 0

    QUEVA CHRISTOPHE CSO AND SVP, RESEARCH

    • Officer
    		 82,500 2022-03-01 0

    GOLDBERG JOHN MAYER CHIEF MEDICAL OFFICER

    • Officer
    		 84,500 2022-03-01 0

    GADICKE ANSBERT

    • 10% Owner
    		 13,553,006 2020-10-06 0

    MPM BIOVENTURES 2014, L.P.

    FOLEY TODD

    MPM BIOVENTURES 2014 (B), L.P.

    MPM ASSET MANAGEMENT INVESTORS BV2014 LLC

    MPM BIOVENTURES 2014 LLC

    MPM BIOVENTURES 2014 GP LLC

    MPM ASSET MANAGEMENT LLC

    • 10% Owner
    		 2,849,453 2020-10-06 0

    UBS ONCOLOGY IMPACT FUND L.P.

    ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

    MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

    MPM ONCOLOGY IMPACT MANAGEMENT LP

    • 10% Owner
    		 2,377,025 2020-10-06 0

    MPM SUNSTATES FUND, L.P.

    MPM ASSET MANAGEMENT INVESTORS SUNSTATES FUND LLC

    MPM SUNSTATES FUND GP LLC

    MPM SUNSTATES GP MANAGING MEMBER LLC

    • 10% Owner
    		 2,849,453 2020-10-06 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ONCORUS INC ONCR 2023-12-05 17:45:04 UTC -10.0621 15.3821 200000
    ONCORUS INC ONCR 2023-12-05 17:15:04 UTC -10.0621 15.3821 200000
    ONCORUS INC ONCR 2023-12-05 16:45:04 UTC -10.0621 15.3821 200000
    ONCORUS INC ONCR 2023-12-05 16:15:04 UTC -10.0621 15.3821 200000
    ONCORUS INC ONCR 2023-12-05 15:45:04 UTC -10.0621 15.3821 200000
    ONCORUS INC ONCR 2023-12-05 15:15:05 UTC -10.0621 15.3821 200000
    ONCORUS INC ONCR 2023-12-05 14:45:03 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-05 14:15:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-05 13:45:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-05 13:15:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-05 12:45:05 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 22:15:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 21:45:03 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 21:15:03 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 20:45:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 20:15:05 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 19:45:03 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 19:15:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 18:45:04 UTC -10.1062 15.4262 200000
    ONCORUS INC ONCR 2023-12-04 18:15:05 UTC -10.1062 15.4262 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments